Legend Biotech Corporation - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Legend Biotech Corporation - ADR
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Frequently asked questions
To buy Legend Biotech Corporation - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Legend Biotech Corporation - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Legend Biotech Corporation - ADR is LEGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Legend Biotech Corporation - ADR has its primary listing on NASDAQ. You can trade Legend Biotech Corporation - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Legend Biotech Corporation - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Legend Biotech Corporation - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Legend Biotech Corporation - ADR or others.